Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2008
11/13/2008WO2008076805B1 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors
11/13/2008WO2008065500A3 Heteroaryl amides as type i glycine transport inhibitors
11/13/2008WO2007145563A8 Benzimidazole derivatives which are to be used as antagonist for the cb1-receptor
11/13/2008US20080281102 Methods and Compounds For Preparing Cc-1065 Analogs
11/13/2008US20080281097 Process for Preparing an Angiotensin II Receptor Antagonist
11/13/2008US20080280964 Novel Antibiotics Comprising Bis(1-Aryl-5-Tetrazolyl)Methane Derivatives
11/13/2008US20080280925 Amines as Small Molecule Inhibitors
11/13/2008US20080280923 1-Benzylindole-2-Carboxamide Derivatives
11/13/2008US20080280921 Amorphous Aripiprazole and Process for the Preparation thereof
11/13/2008US20080280920 Plasminogen Activator Inhibitor-1 Inhibitors
11/13/2008US20080280917 Nitrogen-Containing heterocyclyl ketones and methods of use
11/13/2008US20080280911 Cinnoline Compounds as Inhibitors of Phosphodiesterase Type IV (Pde4)
11/13/2008US20080280909 New phenylalanine derivatives
11/13/2008US20080280906 Imidazolyl-Pyrimidine Compounds for Use in the Treatment of Proliferative Disorders
11/13/2008US20080280903 antiapoptosis agents such as 1-[2-Methoxyimino-2-(4-pyrrolidin-1-yl-phenyl)-ethyl]-quinolinium bromide, used for cytoprotection or for side effect reduction of anticarcinogenic agents
11/13/2008US20080280896 Dipyrrole Compounds, Compositions, and Methods For Treating Cancer or Viral Diseases
11/13/2008US20080280895 5-Amino-4-Hydroxy-7-(1H-Indolmethyl)-8-Methylnonamide Derivatives as Renin Inhibitors for the Treatment of Hypertension
11/13/2008US20080280889 Cancer; N,N-dimethyl-5-phenyl-6-(4-{[4-(5-pyridin-2-yl-1H-pyrazol-3-yl)piperidin-1-yl]methyl}phenyl) pyridazin-3-amine;; serine/threonine kinase (Akt) suppression; increased cellular potency or solubility, enhanced pharmacokinetic properties
11/13/2008US20080280877 Azetidines
11/13/2008US20080280874 Phenoxy Benzamide Compounds with Utility in the Treatment of Type 2 Diabetes and Obesity
11/13/2008US20080280873 Biaryl Substituted Pyrazinones as Sodium Channel Blockers
11/13/2008US20080280872 Benzamide Derivatives and Their Use as Glucokinase Activating Agents
11/13/2008US20080280869 Therapy for diseases resulting from mutation of messenger Rna; suppression prenature translation termination; autoimmune diseases; blood disorders; collagen disease; diabetes; neurodegenerative diseases; cardiovascular disorders; central nervous system disorders; antiinflammatory agents
11/13/2008US20080280855 Process For the Production of Intermediates For the Preparation of Tricyclic Benzimidazoles
11/13/2008US20080279867 Prevent trabsplant rejection; autoimmune diseases
11/13/2008US20080277622 Oxygen Scavenging Molecules, Articles Containing Same, And Methods Of Their Use
11/13/2008CA2694381A1 Aminopyrimidines useful as kinase inhibitors
11/13/2008CA2688584A1 Aminopyrimidines useful as kinase inhibitors
11/13/2008CA2686457A1 Novel polymorphic forms
11/13/2008CA2686033A1 Processes for preparing (r)-2-methylpyrrolidine and (s)-2-methylpyrrolidine and tartrate salts thereof
11/12/2008EP1990337A1 Quinazoline derivatives,preparation methods and uses thereof
11/12/2008EP1990335A1 17 beta hsd type 5 inhibitor
11/12/2008EP1989198A1 2,4-diaminopyrimidine derivatives for the treatment and/or prevention of cancer, infections, inflammatory and autoimmune disorders
11/12/2008EP1989197A1 Pyrazolylquinazolinones as potassium channel openers
11/12/2008EP1989188A1 Therapeutic piperazines as pde4 inhibitors
11/12/2008EP1988900A2 Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators
11/12/2008EP1988777A2 Pyrazoles for the treatment of obesity and other cns disorders
11/12/2008EP1912976B1 Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as v1a receptor antagonists
11/12/2008EP1751138B9 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2008EP1732918B1 Novel pyrrolidine-3,4-dicarboxamide derivatives
11/12/2008EP1727808B1 Biaryl amino acids and their use in dna binding oligomers
11/12/2008EP1705989B1 Substituted arylpyrazoles as parasiticidal agents
11/12/2008EP1703905B1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors
11/12/2008EP1532117B1 Multi-substituded imidazolines and method of use thereof
11/12/2008EP1343503B1 Heteroaryl urea neuropeptide y y5 receptor antagonists
11/12/2008CN101304991A Indole derivatives as antitumoural compounds
11/12/2008CN101304989A Carbocyclic fused cyclic amines as inhibitors of the coagulation factor XA
11/12/2008CN101302182A Virus polymerase inhibitors
11/12/2008CN100432072C Salts and polymorphs of a pyrrole-substituted indolinone compound
11/12/2008CN100432071C Substituted 1H-indole-2-ketone compound and its preparation method and uses
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432059C Quinazolinone derivatives useful as anti-hyperalgesic agents
11/12/2008CN100432051C Coupling product between tryptamine and alpha-amino acid, process for its prepn. as well as its application in neurocosmetic field
11/11/2008US7449576 potent antagonists of the CCR1 receptor; inflammation; (5-Chloro-2-piperazin-1-yl-phenyl)-phenyl-methanone
11/11/2008US7449575 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection
11/11/2008US7449479 Hepatitis C virus inhibitors
11/11/2008US7449474 Tri-substituted ureas as cytokine inhibitors
11/11/2008US7449471 5-phenylpyrimidines, their preparation, compositions comprising them and their use
11/11/2008US7449467 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
11/11/2008US7449465 glycogen synthase kinase 3 alpha and 3 beta inhibitors; improved phanrmacological activity, potency, selectivity, solubility, permeability, metabolic stability; bipolar disorder; Alzheimer's disease; type II diabetes, neuropathic pain; depression; inflammatory diseases
11/11/2008US7449464 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient
11/11/2008US7449456 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide
11/11/2008US7449455 1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol; contraception; melanoma; capable of inhibiting bone loss while showing little or no uterine stimulation, decrease the weight gain, decrease cholesterol levels, prevent bone loss
11/06/2008WO2008133955A1 6-phenylpyrimidinones as pim modulators
11/06/2008WO2008133155A1 Bicyclic heterocyclic compound
11/06/2008WO2008132505A1 N' - (phenyl) -n- (morpholin-4-yl-pyridin-2-yl) -pyrimidine-2, 4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions
11/06/2008WO2008132502A1 Pyrazolyl-amino-substituted pyrimidines and their use for the treatment of cancer
11/06/2008WO2008132211A1 Amino-quinazolinone derivatives for use as radiotracers and imaging agents
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008131779A1 Isoquinolinone derivatives as nk3 antagonists
11/06/2008WO2008131582A1 The method for making candixatan ester and intermediates thereof
11/06/2008WO2008107799A3 Improved process for preparing irbesartan
11/06/2008WO2008106151A3 Co-crystals and pharmaceutical compositions comprising the same
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008076046A8 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
11/06/2008WO2008073933A3 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
11/06/2008WO2008072053A3 Substituted arylpyrazoles
11/06/2008WO2008070358A3 N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain
11/06/2008WO2008024977A3 Isoquinoline, quinazoline and phthalazine derivatives
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275103 Reacting pyrrolylalkylcarbinole, furanylalkylcarbinole or thiophenylalkylcarbinole units; cyclodehydration, hydroboration, oxidation, palladium-catalyzed Suzuki-Miyaura cross-coupling; anticarcinogenic agents, antitumor, and antiproliferative agents; autoimmune and neurodegenerative diseases
11/06/2008US20080275092 Aryl-substituted pyrazole-amide compounds useful as kinase inhibitors
11/06/2008US20080275070 Aryl Ether Compounds and Their Preparation and Use Thereof
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275064 N-(2-Furan-2-yl-6-pyrazol-1-yl-pyrimidin-4-yl)-2-piperidin-1-yl-acetamide; antiischemic agents, antidiabetics; autoimmune diseases, Asthma, Obesity, Huntington's Disease, Dystonia, Dyskinesias, Parkinson's Disease, Inflammatory Bowl Disease
11/06/2008US20080275061 Method for controlling particular insect pests by applying anthranilamide compounds
11/06/2008US20080275055 4-(4-methyl-piperazin-1-ylmethyl-benzoic acid with N-(5- amino-2-methylphenyl)-4-(3pyridyl)-2-pyrimidine-amine in the presence of a coupling reagent such as 2-(5-norborene-2,3- dicarboximido)- 1,1,3,3-tetramethyluronium tetrafluoroborate to produce imatinib, salt formation wtih methanesululfonic acid
11/06/2008US20080275048 Substituted Diazabicycloalkane Derivates
11/06/2008US20080275045 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-propylamine; 2-(3,5-Dimethyl-pyrazol-1-yl)-quinazolin-4-yl]-(4-morpholin-4-yl-phenyl)-amine; respiratory diseases, epilepsy, convulsions, seizures, gastrointestinal dysfunction, ischaemia, psychosis, schizophrenia, anxiety, depression, Alzheimer's disease
11/06/2008US20080275043 Cycloalkyl Lactam Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase 1
11/06/2008US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia
11/06/2008US20080275029 Compounds for Treating Protein-Kinase Mediated Disorders
11/06/2008US20080275027 Piperazinone Derivatives Useful as Histamine H3 Receptor Antagonists and/or Inverse Agonists
11/06/2008US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide
11/06/2008US20080275022 Substituted Quinazolones as Anti-Cancer Agents
11/06/2008US20080275021 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
11/06/2008US20080275009 Oral administration of n-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-1,3-thiazole-5-carboxamide and salts thereof
11/06/2008US20080275004 N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
11/06/2008US20080274947 Antilipemic agents; metabolic disorders; insulin resistance; antidiabetic agents
11/06/2008CA2687943A1 N'-(phenyl)-n-(morpholin-4-yl-pyridin-2-yl)-pyrimidine-2,4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions
1 ... 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 ... 626